Champions Oncology Inc. (CSBR)
NASDAQ: CSBR
· Real-Time Price · USD
7.72
0.50 (6.93%)
At close: Jun 27, 2025, 3:59 PM
7.76
0.52%
After-hours: Jun 27, 2025, 04:04 PM EDT
6.93% (1D)
Bid | 5.54 |
Market Cap | 106.74M |
Revenue (ttm) | 58.59M |
Net Income (ttm) | 6.43M |
EPS (ttm) | 0.45 |
PE Ratio (ttm) | 17.16 |
Forward PE | 33.86 |
Analyst | Strong Buy |
Ask | 8.06 |
Volume | 32,113 |
Avg. Volume (20D) | 36,616 |
Open | 7.36 |
Previous Close | 7.22 |
Day's Range | 7.36 - 7.76 |
52-Week Range | 3.60 - 11.99 |
Beta | 0.37 |
About CSBR
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CSBR
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CSBR stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Champions Oncology Inc. is scheduled to release its earnings on Jul 17, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
6 months ago
+12.09%
Champions Oncology shares are trading higher after...
Unlock content with
Pro Subscription
9 months ago
+9.58%
Champions Oncology shares are trading higher after the company reported better-than-expected Q1 financial results. Also, Craig-Hallum upgraded the stock from Hold to Buy and maintained its $6 price target.